The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine

Irfan A. Qureshi, Mark F. Mehler

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The transplantation of exogenous stem cells and the activation of endogenous neural stem and progenitor cells (NSPCs) are promising treatments for stroke. These cells can modulate intrinsic responses to ischemic injury and may even integrate directly into damaged neural networks. However, the neuroprotective and neural regenerative effects that can be mediated by these cells are limited and may even be deleterious. Epigenetic reprogramming represents a novel strategy for enhancing the intrinsic potential of the brain to protect and repair itself by modulating pathologic neural gene expression and promoting the recapitulation of seminal neural developmental processes. In fact, recent evidence suggests that emerging epigenetic mechanisms are critical for orchestrating nearly every aspect of neural development and homeostasis, including brain patterning, neural stem cell maintenance, neurogenesis and gliogenesis, neural subtype specification, and synaptic and neural network connectivity and plasticity. In this review, we survey the therapeutic potential of exogenous stem cells and endogenous NSPCs and highlight innovative technological approaches for designing, developing, and delivering epigenetic therapies for targeted reprogramming of endogenous pools of NSPCs, neural cells at risk, and dysfunctional neural networks to rescue and restore neurologic function in the ischemic brain.

Original languageEnglish (US)
Pages (from-to)294-302
Number of pages9
JournalArchives of Neurology
Volume68
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Regenerative Medicine
Neural Stem Cells
Epigenomics
Cell Biology
Stem Cells
Stroke
Brain
Neurogenesis
Stem Cell Transplantation
Nervous System
Homeostasis
Therapeutics
Maintenance
Gene Expression
Epigenetics
Cells
Wounds and Injuries
Neural Networks

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

The emerging role of epigenetics in stroke : III. Neural stem cell biology and regenerative medicine. / Qureshi, Irfan A.; Mehler, Mark F.

In: Archives of Neurology, Vol. 68, No. 3, 03.2011, p. 294-302.

Research output: Contribution to journalArticle

@article{5733ee75c240425da2a280b877b5a52d,
title = "The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine",
abstract = "The transplantation of exogenous stem cells and the activation of endogenous neural stem and progenitor cells (NSPCs) are promising treatments for stroke. These cells can modulate intrinsic responses to ischemic injury and may even integrate directly into damaged neural networks. However, the neuroprotective and neural regenerative effects that can be mediated by these cells are limited and may even be deleterious. Epigenetic reprogramming represents a novel strategy for enhancing the intrinsic potential of the brain to protect and repair itself by modulating pathologic neural gene expression and promoting the recapitulation of seminal neural developmental processes. In fact, recent evidence suggests that emerging epigenetic mechanisms are critical for orchestrating nearly every aspect of neural development and homeostasis, including brain patterning, neural stem cell maintenance, neurogenesis and gliogenesis, neural subtype specification, and synaptic and neural network connectivity and plasticity. In this review, we survey the therapeutic potential of exogenous stem cells and endogenous NSPCs and highlight innovative technological approaches for designing, developing, and delivering epigenetic therapies for targeted reprogramming of endogenous pools of NSPCs, neural cells at risk, and dysfunctional neural networks to rescue and restore neurologic function in the ischemic brain.",
author = "Qureshi, {Irfan A.} and Mehler, {Mark F.}",
year = "2011",
month = "3",
doi = "10.1001/archneurol.2011.6",
language = "English (US)",
volume = "68",
pages = "294--302",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - The emerging role of epigenetics in stroke

T2 - III. Neural stem cell biology and regenerative medicine

AU - Qureshi, Irfan A.

AU - Mehler, Mark F.

PY - 2011/3

Y1 - 2011/3

N2 - The transplantation of exogenous stem cells and the activation of endogenous neural stem and progenitor cells (NSPCs) are promising treatments for stroke. These cells can modulate intrinsic responses to ischemic injury and may even integrate directly into damaged neural networks. However, the neuroprotective and neural regenerative effects that can be mediated by these cells are limited and may even be deleterious. Epigenetic reprogramming represents a novel strategy for enhancing the intrinsic potential of the brain to protect and repair itself by modulating pathologic neural gene expression and promoting the recapitulation of seminal neural developmental processes. In fact, recent evidence suggests that emerging epigenetic mechanisms are critical for orchestrating nearly every aspect of neural development and homeostasis, including brain patterning, neural stem cell maintenance, neurogenesis and gliogenesis, neural subtype specification, and synaptic and neural network connectivity and plasticity. In this review, we survey the therapeutic potential of exogenous stem cells and endogenous NSPCs and highlight innovative technological approaches for designing, developing, and delivering epigenetic therapies for targeted reprogramming of endogenous pools of NSPCs, neural cells at risk, and dysfunctional neural networks to rescue and restore neurologic function in the ischemic brain.

AB - The transplantation of exogenous stem cells and the activation of endogenous neural stem and progenitor cells (NSPCs) are promising treatments for stroke. These cells can modulate intrinsic responses to ischemic injury and may even integrate directly into damaged neural networks. However, the neuroprotective and neural regenerative effects that can be mediated by these cells are limited and may even be deleterious. Epigenetic reprogramming represents a novel strategy for enhancing the intrinsic potential of the brain to protect and repair itself by modulating pathologic neural gene expression and promoting the recapitulation of seminal neural developmental processes. In fact, recent evidence suggests that emerging epigenetic mechanisms are critical for orchestrating nearly every aspect of neural development and homeostasis, including brain patterning, neural stem cell maintenance, neurogenesis and gliogenesis, neural subtype specification, and synaptic and neural network connectivity and plasticity. In this review, we survey the therapeutic potential of exogenous stem cells and endogenous NSPCs and highlight innovative technological approaches for designing, developing, and delivering epigenetic therapies for targeted reprogramming of endogenous pools of NSPCs, neural cells at risk, and dysfunctional neural networks to rescue and restore neurologic function in the ischemic brain.

UR - http://www.scopus.com/inward/record.url?scp=79952596383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952596383&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2011.6

DO - 10.1001/archneurol.2011.6

M3 - Article

C2 - 21403016

AN - SCOPUS:79952596383

VL - 68

SP - 294

EP - 302

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 3

ER -